Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PharmX Technologies's Enterprise Value is A$83.24 Mil.
PharmX Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.71 Mil. Therefore, PharmX Technologies's EV-to-EBIT ratio for today is -117.07.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, PharmX Technologies's Enterprise Value is A$83.24 Mil.
PharmX Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.67 Mil. Therefore, PharmX Technologies's EV-to-EBITDA ratio for today is 123.50.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, PharmX Technologies's Enterprise Value is A$83.24 Mil.
PharmX Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$7.49 Mil. Therefore, PharmX Technologies's EV-to-Revenue ratio for today is 11.12.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
PharmX Technologies (ASX:PHX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
PharmX Technologies's current Enterprise Value is A$83.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PharmX Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.71 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
PharmX Technologies's current Enterprise Value is A$83.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PharmX Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.67 Mil.
PharmX Technologies's current Enterprise Value is A$83.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PharmX Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$7.49 Mil.
PharmX Technologies's current Enterprise Value is A$83.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PharmX Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.01 Mil.
PharmX Technologies's current Enterprise Value is A$83.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PharmX Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmX Technologies Enterprise Value Related Terms
PharmX Technologies Enterprise Value Historical Data
* Premium members only.
The historical data trend for PharmX Technologies's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:PHX vs VEEV, BTSG, TEM: Enterprise Value Comparison
For the Health Information Services subindustry, PharmX Technologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmX Technologies Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where PharmX Technologies's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
PharmX Technologies's Enterprise Value for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmX Technologies (ASX:PHX) has a Enterprise Value of A$83.24 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on PharmX Technologies and its competitors.
Is PharmX Technologies' Enterprise Value too high?
PharmX Technologies' current Enterprise Value is A$83.24 Mil. Overall, PharmX Technologies has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PharmX Technologies' Enterprise Value compare to VEEV and BTSG?
PharmX Technologies' Enterprise Value of A$83.24 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on PharmX Technologies and its competitors. PharmX Technologies's current Enterprise Value is A$83.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmX Technologies stock overvalued right now?
Based on GuruFocus' analysis, PharmX Technologies (ASX:PHX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.07, compared to a current price of A$0.13 — trading 85.7% above its estimated fair value. The current Enterprise Value is A$83.24 Mil. PharmX Technologies' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For PharmX Technologies (ASX:PHX), the current Enterprise Value is A$83.24 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmX Technologies (ASX:PHX) Overvalued in 2026?
Based on GuruFocus' analysis, PharmX Technologies stock appears to be overvalued.
The current stock price of A$0.13 is trading 85.7% above its estimated GF Value™ of A$0.07.
GuruFocus considers PharmX Technologies to be Significantly Overvalued.
Key valuation signals for ASX:PHX:
Enterprise Value: A$83.24 Mil
GF Value™: A$0.07 vs. price of A$0.13 (85.7% above fair value)
No single metric tells the full story. See the ASX:PHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
40GF Score
Get the complete analysis for ASX:PHX
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PHX has been successfully added to your 
